Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAge Labs (BIOA) Non-cash Items (2023 - 2026)

BioAge Labs' Non-cash Items history spans 3 years, with the latest figure at $46.2 million for Q4 2025.

  • On a quarterly basis, Non-cash Items rose 4425.05% to $46.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $46.2 million, a 4425.05% increase, with the full-year FY2025 number at $46.2 million, up 4425.05% from a year prior.
  • Non-cash Items hit $46.2 million in Q4 2025 for BioAge Labs, up from $5.5 million in the prior quarter.
  • Over the last five years, Non-cash Items for BIOA hit a ceiling of $59.5 million in Q3 2024 and a floor of $155000.0 in Q1 2025.
  • Historically, Non-cash Items has averaged $16.5 million across 3 years, with a median of $2.9 million in 2023.
  • The widest YoY moves for Non-cash Items: up 4425.05% in 2025, down 90.78% in 2025.
  • Tracing BIOA's Non-cash Items over 3 years: stood at $2.9 million in 2023, then plummeted by 64.32% to $1.0 million in 2024, then surged by 4425.05% to $46.2 million in 2025.
  • Business Quant data shows Non-cash Items for BIOA at $46.2 million in Q4 2025, $5.5 million in Q3 2025, and $271000.0 in Q2 2025.